|Other Names||MAP3K7 C-terminal-like protein, TAK1-like protein, MAP3K7CL, C21orf7, TAK1L|
|Format||Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Detected in lung and peripheral blood leukocytes. Expressed predominantly in peripheral blood leukocytes and ubiquitously in adult and fetal tissues. Also expressed strongly in breast carcinoma GI-101, colon adenocarcinoma GI-112, and prostatic adenocarcinoma PC3|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
TAK1L plays a critical role in the TGF beta signaling transduction pathway.
Hu, Y.H., et al. BMC Genomics 7, 155 (2006) :Li, J., et al. Biochem. Genet. 42 (3-4), 129-137 (2004) :Hillman, R.T., et al. Genome Biol. 5 (2), R8 (2004) :Reymond, A., et al. Genomics 78 (1-2), 46-54 (2001) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.